Research ArticleLETTERS TO THE EDITOR
Response to Comments on “Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel”
Deshi Shi, Jian Yang, Dongfang Yang, Edward L. LeCluyse, Chris Black, Li You, Fatemeh Akhlaghi and Bingfang Yan
Journal of Pharmacology and Experimental Therapeutics July 2007, 322 (1) 424-425; DOI: https://doi.org/10.1124/jpet.107.120030
Deshi Shi
Jian Yang
Dongfang Yang
Edward L. LeCluyse
Chris Black
Li You
Fatemeh Akhlaghi
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleLETTERS TO THE EDITOR
Response to Comments on “Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel”
Deshi Shi, Jian Yang, Dongfang Yang, Edward L. LeCluyse, Chris Black, Li You, Fatemeh Akhlaghi and Bingfang Yan
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 424-425; DOI: https://doi.org/10.1124/jpet.107.120030
Research ArticleLETTERS TO THE EDITOR
Response to Comments on “Anti-Influenza Prodrug Oseltamivir Is Activated by Carboxylesterase Human Carboxylesterase 1, and the Activation Is Inhibited by Antiplatelet Agent Clopidogrel”
Deshi Shi, Jian Yang, Dongfang Yang, Edward L. LeCluyse, Chris Black, Li You, Fatemeh Akhlaghi and Bingfang Yan
Journal of Pharmacology and Experimental Therapeutics July 1, 2007, 322 (1) 424-425; DOI: https://doi.org/10.1124/jpet.107.120030
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement